KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Cash from Operations (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Cash from Operations for 11 consecutive years, with 192652000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations rose 1.04% year-over-year to 192652000.0, compared with a TTM value of 713223000.0 through Dec 2025, up 17.15%, and an annual FY2025 reading of 713223000.0, up 17.15% over the prior year.
  • Cash from Operations was 192652000.0 for Q4 2025 at Medpace Holdings, down from 246209000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 246209000.0 in Q3 2025 and bottomed at 46256000.0 in Q1 2022.
  • Average Cash from Operations over 5 years is 120339450.0, with a median of 115391000.0 recorded in 2023.
  • The sharpest move saw Cash from Operations crashed 32.8% in 2021, then soared 92.8% in 2022.
  • Year by year, Cash from Operations stood at 70894000.0 in 2021, then skyrocketed by 92.8% to 136684000.0 in 2022, then grew by 14.42% to 156395000.0 in 2023, then increased by 21.91% to 190666000.0 in 2024, then rose by 1.04% to 192652000.0 in 2025.
  • Business Quant data shows Cash from Operations for MEDP at 192652000.0 in Q4 2025, 246209000.0 in Q3 2025, and 148526000.0 in Q2 2025.